Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    0.00 (0.00%)
Bid:
26.25
Ask:
28.00
Spread: 1.75 (6.667%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

AGM Statement

6 Sep 2017 07:00

RNS Number : 8792P
Severfield PLC
06 September 2017
 

6 September 2017

Severfield plc

('the Company' or 'the Group')

AGM trading update

 

 

At the Company's Annual General Meeting, to be held today at 12.00 noon, Aldwark Manor Hotel, Aldwark, Alne, York YO61 1UF, the Chairman, John Dodds, will make the following statement.

 

Current trading and outlook

The Group's trading performance and financial position remains in line with management expectations and the outlook for the year ending 31 March 2018 remains unchanged. As a result of the current phasing of contract works, the results for the full year are expected to be more first half weighted than in the prior year.

 

UK

The UK order book of £221m as at 1 September (1 June: £229m) remains healthy with a good mix of projects, and is in line with our normal order book levels which typically equate to eight to ten months of annualised revenue. Both the quality of the order book and the strength of the UK pipeline are consistent with our continued progress towards our strategic targets.

 

India

Operational performance remains good and the repayment of the joint venture's term debt in June 2017 will benefit current year profitability. With an order book of £64m at 1 September (1 June: £73m) and an encouraging level of new opportunities, the Indian business is well positioned to take advantage of an improving local economy.

 

Half year results

The Group will announce its financial results for the half year ending 30 September 2017 on 21 November 2017.

 

 

For further information, please contact:

 

 

Severfield plc

Alan Dunsmore

01845 577 896

 

Acting Chief Executive Officer

 

 

 

Adam Semple

01845 577 896

 

Acting Group Finance Director

 

 

Jefferies International Limited

Simon Hardy

020 7029 8000

 

Will Soutar

 

020 7029 8000

Bell Pottinger

Dan de Belder

020 3772 2561

 

Zara de Belder

020 3772 2512

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMMMGGLFKRGNZM
Date   Source Headline
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details
7th Dec 20213:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:17 pmRNSIssue of Ordinary Shares
23rd Nov 20217:57 amRNSProgressive publishes new research
23rd Nov 20217:01 amRNSInterim Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.